CNS Pharmaceuticals Inc (CNSP)
0.1409
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.135
-0.01
(-4.19%)
After-Hours: 20:00
CNS Pharmaceuticals Cash from Operations (Quarterly): -1.650M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.650M |
| March 31, 2024 | -3.192M |
| December 31, 2023 | -2.536M |
| September 30, 2023 | -3.376M |
| June 30, 2023 | -3.403M |
| March 31, 2023 | -4.825M |
| December 31, 2022 | -2.305M |
| September 30, 2022 | -1.813M |
| June 30, 2022 | -3.362M |
| March 31, 2022 | -3.077M |
| December 31, 2021 | -3.237M |
| Date | Value |
|---|---|
| September 30, 2021 | -1.996M |
| June 30, 2021 | -4.998M |
| March 31, 2021 | -3.308M |
| December 31, 2020 | -1.447M |
| September 30, 2020 | -1.274M |
| June 30, 2020 | -2.742M |
| March 31, 2020 | -1.855M |
| December 31, 2019 | -2.476M |
| September 30, 2019 | -0.3783M |
| June 30, 2019 | -0.6169M |
| March 31, 2019 | -0.0827M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.998M
Minimum
Jun 2021
-0.3783M
Maximum
Sep 2019
-2.662M
Average
-2.639M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 2.327M |
| Free Cash Flow | -10.76M |
| Free Cash Flow Per Share (Quarterly) | -4.382 |
| Free Cash Flow Yield | -40.24K% |